Ryan Cohlhepp

Insider Reports History

Location
Boston, MA
Signature
/s/ Lara Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ryan Cohlhepp:

Company Role Class Num Shares Value Price $ Report Date Ownership
Bicara Therapeutics Inc. President and COO, Director Common Stock 210,164 $3,804,472 $18.10 22 Jan 2026 Direct
Bicara Therapeutics Inc. President and COO, Director Stock Option (Right to Buy) 300,000 02 Feb 2026 Direct

Insider Reports Filed by Ryan Cohlhepp

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCAX Bicara Therapeutics Inc. 02 Feb 2026 1 $0 4 President and COO, Director 04 Feb 2026, 16:38
BCAX Bicara Therapeutics Inc. 22 Jan 2026 1 -$69,296 4 President and COO, Director 26 Jan 2026, 16:34
BCAX Bicara Therapeutics Inc. 15 Jan 2026 1 -$2,685 4 President and COO, Director 20 Jan 2026, 16:52
BCAX Bicara Therapeutics Inc. 26 Dec 2025 2 +$110,922 4 President and COO, Director 29 Dec 2025, 17:18
BCAX Bicara Therapeutics Inc. 15 Dec 2025 4 -$203,229 4 President and COO, Director 16 Dec 2025, 16:52
BCAX Bicara Therapeutics Inc. 21 Nov 2025 4 -$195,269 4 President and COO, Director 25 Nov 2025, 18:41
BCAX Bicara Therapeutics Inc. 15 Oct 2025 4 -$196,624 4 President and COO, Director 16 Oct 2025, 16:41
BCAX Bicara Therapeutics Inc. 06 Oct 2025 8 -$790,568 4 President and COO, Director 08 Oct 2025, 17:33
BCAX Bicara Therapeutics Inc. 12 Sep 2024 0 $0 3 President and COO 12 Sep 2024, 21:07